Evidence map›Paper›PMID 35172614›Full record

ArticleAIDS research and human retroviruses2022

Deborah H Fuller, Megan A O'Connor

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and human retroviruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Deborah H FullerDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Megan A O'ConnorDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
University of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
WaNPRC Macaca nemestrina SPF Breeding ColonyU42OD011123 · OD · UNIVERSITY OF WASHINGTON · PI CHARLOTTE HOTCHKISS · 2012 to 2026
$34.4M
Programming protective immunity by targeting antigens to the CD180 receptorR01AI052203 · NIAID · UNIVERSITY OF WASHINGTON · PI FULLER, DEBORAH H. · 2003 to 2019
$6.3M
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patientsR56AI141494 · NIAID · UNIVERSITY OF WASHINGTON · PI FULLER, DEBORAH H. · 2019 to 2019
$908k
Evaluating risks of ZIKV co-infection in SIV-infected macaquesK01MH123258 · NIMH · UNIVERSITY OF WASHINGTON · PI O'CONNOR, MEGAN A · 2020 to 2022
$346k
NIAID NIH HHS R01 AI052203NIAID NIH HHS R56 AI141494NIH HHS P51 OD010425NIH HHS U42 OD011123NIMH NIH HHS K01 MH123258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoccidioidomycosisHIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsDisease Models, AnimalHumansImmunogenicity, VaccinePrimatesanimal modelscoccidioidomycosisHIV/AIDSHIV/SIV disease pathogenesisnonhuman primate modelspigtail macaquesimian immunodeficiency virusvaccine immunogenicityvaccinesValley Fever

Identifiers

PMID35172614
PMCPMC9131037
OpenAlexW4212811543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.